Skip to main content
. 2021 Jul 1;99(7):skab157. doi: 10.1093/jas/skab157

Table 2.

Meta-analysis (effect sizes) of studies measuring challenge bacteria concentrations following application of phage in pigs

Parameter I2, % Effect size Effect significance, P-value Power, % No. observations, Treatment No. observations, Control Total observations
All observations together 64.2 −1.06 <0.0001 100 336 240 576
Sampling Time
 Samples collected ≤24 h post-phage treatment 57.4 −0.82 0.0007 96.96 252 156 408
 Samples collected 48–96 h post-phage treatment 36.6 −1.78 0.022 99.72 84 84 168
Age of Pig
 Piglets 62.8 −1.31 0.0001 100 216 174 390
  Piglets, samples collected ≤24 h post-phage treatment 65.8 −1.075 0.0037 99.97 132 90 222
  Piglets, samples collected 48–96 h post-phage treatment 36.6 −1.78 0.022 99.72 84 84 168
 Market Weight Pigs, samples collected ≤24 h post-phage treatment 0 −0.50 0.0138 99.76 120 66 186
Targeted Bacteria
Salmonella 64.2 −0.95 <0.0001 100 312 216 528
  Salmonella, samples collected ≤24 h post-phage treatment 59.3 −0.77 0.002 100 240 144 384
  Salmonella, samples collected 48–96 h post-phage treatment1 0 −1.53 0.002 99.22 72 72 144
E. coli 69.1 −1.89 0.1084 71.46 24 24 48
  E. coli, samples collected ≤24 h post-phage treatment1 66.5 −1.29 0.3743 43.15 12 12 24
  E. coli, samples collected 48–96 h post-phage treatment 82.7 −2.68 0.3622 431.5 12 12 24
Frequency of Phage Application
 Single Dose1 0.0 −0.25 0.0202 80.67 72 18 90
 Multiple Doses 63.4 −1.21 <0.0001 100 264 222 486
  Multiple Doses, samples collected ≤24 h post-phage treatment 60.9 −0.98 0.0011 100 180 138 318
  Multiple Doses, samples collected 48–96 h post-phage treatment 36.6 −1.78 0.022 99.72 84 84 168
Prophylaxis vs. Treatment
 Prophylaxis 0.0 −0.72 0.0017 99.99 144 102 270
  Prophylaxis, samples collected ≤24 h post-phage treatment 0.0 −0.24 0.0017 99.99 144 102 246
 Treatment 71.0 −1.31 0.0025 100 192 138 330
  Treatment, samples collected ≤24 h post-phage treatment 78.4 −0.93 0.0748 99.28 108 54 162
  Treatment, samples collected 48–96 h post-phage treatment 36.6 −1.78 0.022 99.72 84 84 168
Sample Site
 Ileum2 30.4 −0.40 0.0008 99.77 96 78 174
 Cecum 50.6 −0.92 0.0133 99.97 120 102 222
  Cecum, samples collected ≤24 h post-phage treatment 79.2 −0.60 0.2709 99.77 96 78 174
 Feces 69.4 −1.58 0.0062 99.97 120 102 222
  Feces, samples collected ≤24 h post-phage treatment 81.4 −1.28 0.1078 95.28 60 42 102
  Feces, samples collected 48–96 h post-phage treatment 50.6 −1.94 0.0617 97.91 60 60 120
Administration Route
 Gavage 68.9 −1.00 0.0002 100 270 216 486
  Gavage, samples collected ≤24 h post-phage treatment 67.6 −0.82 0.0061 100 198 144 342
  Gavage, samples collected 48–96 h post-phage treatment1 0 −1.53 0.002 99.22 72 72 144
 Feed 62.7 −1.35 0.0631 98.72 66 66 132
  Feed, Gavage, samples collected ≤24 h post-phage treatment 25.5 −0.81 0.0966 96.64 54 54 108
  Feed, samples collected 48–96 h post-phage treatment1 82.7 −2.68 0.3622 43.15 12 12 24
Phage Protection
 Protected 43.2 −1.027 0.0029 100 168 126 294
  Protected, samples collected ≤24 h post-phage treatment 10 −0.80 0.0011 100 156 114 270
  Protected, samples collected ≤24 h post-phage treatment1 82.7 −2.68 0.3622 43.15 12 12 24
 Unprotected 75.7 −1.13 0.0112 100 144 90 234
  Unprotected, samples collected ≤24 h post-phage treatment 85.0 −0.79 0.2307 97.82 96 42 138
  Unprotected, samples collected ≤24 h post-phage treatment1 0.0 −1.53 0.002 99.22 72 72 144

1Only one study; 2Data same as ileum <24 h.